JAMA Analysis of 2024 HINTS Data Shows 21% of US Adults Act on Social Media Health Content They Largely View as Misleading
Despite 79% of users recognizing social media health content as misleading, 21% still base real decisions on it according to JAMA analysis of nationally representative 2024 HINTS data. Older adults and Hispanic respondents show higher uptake; chronic-disease patients engage heavily but share less. The findings highlight an evidence gap between perception and behavior that existing regulatory frameworks have not addressed.
The 2024 Health Information National Trends Survey captured four behaviors among 88% of US adults who use social media: sharing health posts, joining communities, basing decisions on content, and distrust levels. Researchers stratified results by age, ethnicity, education, and chronic disease status. Adults over 65 and Hispanic respondents showed elevated decision-making rates while those with cancer or heart disease used platforms at 85.5% yet shared less. Absolute decision-making prevalence reached 21% overall, equating to roughly 55 million adults.
Market data place the health influencer sector at $1.27 billion in 2026, projected to reach $3.8 billion by 2035. Absence of editorial gatekeeping or conflict-of-interest disclosure allows promotional posts to reach users at scale. Prior HINTS waves from 2018–2022 documented rising online health seeking but predated widespread AI-generated video and algorithmic amplification now driving exposure.
Demographic patterns align with earlier Pew and CDC surveys showing higher trust in peer narratives among older and minority groups. The current study adds that higher education correlates with lower decision rates yet does not eliminate the behavior. Chronic-disease patients appear more cautious about sharing, possibly reflecting prior negative encounters with unverified advice.
Next steps include platform-level labeling trials and targeted clinician outreach to high-risk demographic strata. Without such interventions, the documented gap between stated distrust and observed action is likely to persist through 2027.
VITALIS: FDA will issue platform guidance requiring conflict disclosures on health posts exceeding 10% reach within 24 months.
Sources (2)
- [1]Primary Source(https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.8682)
- [2]Supporting Source(https://www.pewresearch.org/science/2023/10/05/health-information-on-social-media/)